Earnings Feed
Start Free
Home/Filings/4/0001610717-26-000015
4//SEC Filing

Duffy Sean P. 4

Accession 0001610717-26-000015

CIK 0001611115other
View on SEC.govCompany Profile

Filed

Jan 13, 7:00 PM ET

Accepted

Jan 14, 6:01 PM ET

Size

16.6 KB

Accession

0001610717-26-000015

Insider Transaction Report

Form 4
Period: 2026-01-12
Omada Health, Inc.OMDA
Duffy Sean P.
DirectorChief Executive Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2026-01-12$2.55/sh+230,479$587,721→ 357,123 total
  • Sale

    Common Stock

    [F1][F2]
    2026-01-12$15.35/sh−139,989$2,148,425→ 217,134 total
  • Sale

    Common Stock

    [F1][F3]
    2026-01-12$15.99/sh−90,490$1,446,727→ 126,644 total
  • Exercise/Conversion

    Common Stock

    2026-01-13$2.55/sh+40,796$104,030→ 167,440 total
  • Sale

    Common Stock

    [F1][F4]
    2026-01-13$15.95/sh−40,796$650,774→ 126,644 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F6]
    2026-01-12−230,479→ 40,796 total
    Exercise: $2.55Exp: 2026-01-27→ Common Stock (230,479 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F6]
    2026-01-13−40,796→ 0 total
    Exercise: $2.55Exp: 2026-01-27→ Common Stock (40,796 underlying)
Holdings

  • Common Stock

    [F5]
    (indirect: See footnote)
    861,109
Footnotes (6)
  • [F1]Represents shares underlying non-qualified stock options set to expire imminently on January 27, 2026.
  • [F2]This transaction was executed in multiple trades at prices ranging from $14.85 to $15.84. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F3]This transaction was executed in multiple trades at prices ranging from $15.85 to $16.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F4]This transaction was executed in multiple trades at prices ranging from $15.61 to $16.32. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F5]Held in family trusts for the benefit of the Reporting Person's family members. The Reporting Person disclaims beneficial ownership of the shares held by the family trusts except to the extent of his pecuniary interest therein.
  • [F6]The option is fully vested and exercisable.
Signature
/s/ Nathan Salha, as Attorney-in-Fact for Sean P. Duffy|2026-01-14

Documents

1 file

Issuer

Omada Health, Inc.

CIK 0001611115

→
Entity typeother

Related Parties

1
  • filerCIK 0002069522

Filing Metadata

Form type
4
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 6:01 PM ET
Size
16.6 KB
View on SEC.gov